Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|ANBL0421||COG||A Phase II Study of Irinotecan + Temozolomide in Children with Recurrent Neuroblastoma: A Groupwide Phase II Study||Pediatric CIRB||Completed|
|GOG-0277||GOG||A Phase III Randomized Trial of Gemcitabine (NSC# 613327) Plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NCS# 123127) versus Observation for Uterus-Limited; High Grade Uterine Leiomyosarcoma||Adult CIRB - Late Phase Emphasis||Completed|
|CALGB-90206||CALGB||A Randomized Phase III Trial of Interferon Alfa-2B or Interferon Alfa-2B Plus Bevacizumab in Patients with Advanced Renal Carcinoma||Adult CIRB - Late Phase Emphasis||Completed|
|9571||ETCTN||A phase IB study of the combination of AZD6244 hydrogen sulfate (selumetinib) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer||Adult CIRB - Early Phase Emphasis||Completed|
|ASCT0431||COG||A Randomized Trial of Sirolimus-Based Graft versus Host Disease Prophylaxis after Hematopoietic Stem Cell Transplantation in Selected Patients with CR1 and CR2 ALL: A Groupwide Phase III Study||Pediatric CIRB||Completed|
|E3200||ECOG||Phase III Trial of Bevacizumab (NSC 704865); Oxaliplatin (NSC 266046); Fluorouracil and Leucovorin versus Oxaliplatin; Fluorouracil and Leucovorin versus Bevacizumab Alone in Previously Treated Patients with Advanced Colorectal Cancer||Adult CIRB - Late Phase Emphasis||Completed|
|ACNS0621||COG||Cilengitide (EMD 121974) (IND# 59073) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma: A Groupwide Phase II Study||Pediatric CIRB||Completed|
|NSABP-C-11||NSABP||A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients with Potentially Resectable Hepatic Colorectal Metastases||Adult CIRB - Late Phase Emphasis||Completed|
|9824||ETCTN||A Phase 1 Study of alisertib (MLN8237) in combination with mFOLFOX in gastrointestinal tumors||Adult CIRB - Early Phase Emphasis||Completed|
|ACCL0935||COG||Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk||Pediatric CIRB||Completed|